Author

Martin Mense

Cystic Fibrosis FoundationORCID 0000-0003-0280-9789Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Priyanka BhattiD· 2 shared Andrey SivachenkoiD· 1 shared C. Macadino· 1 shared Calvin U. Cotton· 1 shared Hermann J. BihleriD· 1 shared Hillary C. Valley· 1 shared Isabelle S. van der Windt· 1 shared Jae Seok YooniD· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Priyanka BhattORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsbioRxivPreprintJul 1, 2024

Upregulation of a nonsense mediated decay (NMD) insensitive CFTR mRNA isoform has therapeutic potential for the treatment of 3 Prime CFTR PTC variants

Norm Allaire, M. Armstrong, Jae Seok Yoon…·Calvin U. Cotton

The paper shows that upregulating an NMD-insensitive CFTR mRNA isoform with ASOs and ETI can restore partial Cl- transport function in cells with 3' PTC mutations.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky

Molecular BiologybioRxivPreprintJun 6, 2024

Anticodon Engineered Transfer RNAs (ACE-tRNAs) are a Platform Technology for Suppressing Nonsense Mutations

Wooree Ko, Joseph J. Porter, Sacha Spelier…·John D. Lueck

The paper demonstrates that ACE-tRNAs can suppress nonsense mutations in CF by rescuing CFTR transcript abundance and channel function in multiple models.

DOI 10.1101/2024.06.06.597760

humanexperimental assay

𝕏 PostBluesky